Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 8,186,194 $ 20,303,869
Investments 4,933,550 0
Other current assets 45,982 217,745
Total current assets 13,165,726 20,521,614
Operating lease right-of-use asset 61,228 0
Total assets 13,226,954 20,521,614
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 3,128,894 1,580,543
Total current liabilities 3,128,894 1,580,543
Non- current operating lease liability 8,408 0
Total liabilities 3,137,302 1,580,543
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 12,946,573 and 12,598,125 shares issued and outstanding at December 31, 2022, and December 31, 2021, respectively 12,947 12,598
Additional paid-in capital 61,871,784 60,220,016
Accumulated other comprehensive income (loss) 8,942 (3,160)
Accumulated deficit (51,804,021) (41,288,383)
Total stockholders' equity 10,089,652 18,941,071
Total liabilities and stockholders' equity $ 13,226,954 $ 20,521,614